About NightHawk Biosciences
NightHawk Biosciences is a company based in Morrisville (United States) founded in 2008. NightHawk Biosciences has raised $8.13 million across 9 funding rounds from investors including HHS. NightHawk Biosciences has completed 1 acquisition, including Pelican Therapeutics. NightHawk Biosciences operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Morrisville, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
$6.24 M (USD)-59as on Dec 31, 2024
-
Net Profit
-$32.81 M (USD)-1930as on Dec 31, 2024
-
EBITDA
-$33.6 M (USD)20as on Dec 31, 2024
-
Total Equity Funding
$8.13 M (USD)
in 9 rounds
-
Latest Funding Round
$399.11 K (USD), Grant
Sep 19, 2023
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of NightHawk Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of NightHawk Biosciences
NightHawk Biosciences has successfully raised a total of $8.13M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $399.11 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $399,110
-
First Round
First Round
(18 Nov 2009)
- Investors Count 1
Investors in NightHawk Biosciences
NightHawk Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NightHawk Biosciences
NightHawk Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pelican Therapeutics.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing antibody to stimulate memory CD8+ cytotoxic T cells for the treatment of cancer.
|
2011 |
Financial Statements - NightHawk Biosciences
Nighthawk Biosciences Comparisons
Competitors of NightHawk Biosciences
NightHawk Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Latest news on Nighthawk Biosciences
Frequently Asked Questions about NightHawk Biosciences
NightHawk Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
NightHawk Biosciences is headquartered in Morrisville, United States.
NightHawk Biosciences is a funded company, having raised a total of $8.13M across 9 funding rounds to date. The company's 1st funding round was a Grant of $144.16K, raised on Nov 18, 2009.
Annual revenue of NightHawk Biosciences is $6.24M as on Dec 31, 2024.
NightHawk Biosciences was founded in 2008 as a fully integrated biopharmaceutical company based in Morrisville, United States. Operations focus on the discovery, development, and commercialization of therapies in the biotechnology sector. Services encompass preclinical and clinical-stage programs targeting various diseases, with activities managed from U.S. facilities. The companys domain is nighthawkbio.com, supporting its pipeline advancement.
NightHawk Biosciences's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
NightHawk Biosciences has made 1 acquisition, including Pelican Therapeutics.
NightHawk Biosciences has 1 investor. Key investors include HHS.